Abstract Manipulation of gene expression is one of the most informative ways to study gene function. Genetic screens have been an informative method to identify genes involved in developmental processes. In the zebraWsh, lossof-function screens have been the primary approach for these studies. We sought to complement loss-of-function screens using an unbiased approach to overexpress genes with a Gal4-UAS based system, similar to the gain-of-function screens in Drosophila. Using MMLV as a mutagenic vector, a cassette containing a UAS promoter was readily inserted in the genome, often at the 5Ј end of genes, allowing Gal4-dependent overexpression. We conWrmed that genes downstream of the viral insertions were overexpressed in a Gal4-VP16 dependent manner. We further demonstrate that misexpression of one such downstream gene gucy2F, a membrane-bound guanylate cyclase, throughout the nervous system results in multiple defects including a loss of forebrain neurons. This suggests proper control of cGMP production is important in neuronal survival. From this study, we propose that this gain-of-function approach can be applied to large-scale genetic screens in a vertebrate model organism and may reveal previously unknown gene function.
Introduction
One of the most informative ways to study gene function has been to manipulate its expression in a model organism either through loss-of-function or overexpression. While loss-of-function studies can be performed in a non-biased manner, genes with redundant functions may be overlooked. Overexpression studies in vertebrates commonly examine the eVect of a pre-determined set of genes when expressed in a tissue of interest. We sought to develop, in a vertebrate model organism, an unbiased approach to overexpress genes for genetic analysis, similar to the gain-offunction screens that have been done in Drosophila.
ZebraWsh is a well established model system to study vertebrate development and other processes and is amenable to genetic manipulation. One of the key advantages of zebraWsh is the ability to perform large-scale forward genetic screens to identify genes involved in developmental processes. This has been achieved primarily using ENU to mutate genes (Driever et al. 1996; HaVter and NussleinVolhard 1996; Muto et al. 2005) , although insertional mutagenesis mediated by retrovirus (Amsterdam et al. 1999; Golling et al. 2002; Wang et al. 2007) or Tol2 based transposons (Kawakami et al. 2004; Kotani et al. 2006; Asakawa et al. 2008 ) is gaining wider use. While highly informative, forward genetic screens based on recessive phenotype cannot identify mutations in genes with redundant function. In addition, these mutations impact the entire organism, making determination of tissue-speciWc function of the aVected gene very challenging. A complementary approach to the loss-of-function screen is to overexpress genes in a speciWc tissue or cell type and determine phenotypic consequences. In Drosophila, large-scale gain-offunction screens through overexpression of random genes have been used to identify genes involved in speciWc developmental processes (Hay et al. 1997; Rorth et al. 1998; Staudt et al. 2005; Molnar et al. 2006) . Because these mutations are "dominant" and can be controlled spatially and temporally, the gain-of-function screens have identiWed genes that had been unnoticed in loss-of-function screens.
While used extensively in Drosophila, the Gal4-UAS system has not been widely applied in zebraWsh. More recently, Gal4-UAS is being incorporated as a component of gene-trap and enhancer trap screens (Davison et al. 2007; Scott et al. 2007; Asakawa et al. 2008 ). However, these approaches rely primarily on a UAS driven Xuorescent protein as an indicator of the expression pattern of the gene tagged by a Gal4 cassette and often does not signiWcantly impact the expression of the trapped gene itself. In order to examine the function of a gene, its expression would need to be altered. In the Drosophila gain-of-function screens, a Gal4 responsive promoter (UAS) is randomly inserted in the genome by EP elements and genes downstream of these insertions are expressed when the Gal4 activator is present (Rorth 1996; Hay et al. 1997) . For zebraWsh, retrovirus is an appealing vector to deliver the UAS element into the zebraWsh genome. The mouse Moloney leukemia virus (MMLV) has been used by several groups as an insertional mutagen in zebraWsh (Amsterdam et al. 1999; Golling et al. 2002; Ellingsen et al. 2005; Wang et al. 2007) , facilitating loss-of-function screens and providing a tool to quickly identify essential genes in development. MMLV is also uniquely poised to facilitate gainof-function screens since the insertions occurring in genes have been shown to be primarily located at the 5Ј end (Wu et al. 2003; Wang et al. 2007 ). The gain-of-function approach increases the eYciency of phenotype based screens since the analysis can be performed in the F1 generation, in contrast to the F3 generation used for loss-offunction screens. Furthermore, the eVect of all germline insertions in a mosaic founder can be examined, instead of propagating a fraction in selected F1 progeny for the lossof-function screens.
We show here the application of a MMLV mediated gain-of-function strategy with overexpression of genes that lie downstream of the viral insertions. Overexpression of some of these genes in speciWc tissues can lead to a detectable phenotype, showing this approach is valid for a forward genetic screen in a vertebrate system. Additionally, many of the insertions are also expected to inactivate the host gene in the absence of Gal4-based transcription factors, allowing loss-of-function eVects to also be determined.
Materials and methods

Fish husbandry
ZebraWsh were raised in aquatic habitats systems (Apopka, FL) on a 14-10 light/dark cycle as described previously (Chen and Casey Corliss 2004) . Tubingen Wsh were acquired from the ZebraWsh International Resource Center (ZIRC). Tg(ath5:Gal4VP16) Wsh were genotyped for the transgene and maintained as homozygous adults. Embryos were reared in 0.3£ Danieau's solution at 28°C.
Generation of gene-activating virus
The pClnZ plasmid was modiWed to contain the gene-activation cassette in the reverse orientation of LacZ. The gene-activating cassette was generated using 14£ UAS obtained from Dr. Scott Fraser (California Institute of Technology), the synthetic element subcloned from the Gene-Switch plasmid (Invitrogen) and the BGH pA subcloned from pCDNA3.1Myc-His (Invitrogen). The viral packaging cell line 293 gp/bsr (Amsterdam et al. 1999) was grown in Dulbecco's modiWed Eagle medium with 10% fetal calf serum, penicillin and streptomycin. Transfection of 293 gp/bsr cells, transduction and selection of individual cells by FACS was performed as previously described . When individual clones became conXuent, the viral titer from these clones was assessed by QPCR . In this assay, viral titer is determined by examining Ct values for viral DNA compared to the Ct values for the endogenous Rag1 gene [ Ct = Ct(virus) ¡ Ct(Rag1)]. In this comparison, a more negative number indicates more viral copies are present. To compare virus producing clones, a Ct value is determined by comparing the Ct of a selected clone to the control GT186 [ Ct = Ct(clone) ¡ Ct(control)]. Once again, a negative number indicates more viral copies are present in cells infected with the test clones than with the control. Clones producing the highest titer in the initial assay were scaled up to 10 cm dishes. For large-scale virus preparation, viral producing cells were plated on poly-L-lysine coated 15 cm dishes for 90% conXuency. Cells were transfected overnight with CMVG and Lipofectamine 2000 using conditions yielding the optimal viral titer. For clone 10D11, optimal transfection condition was 5 g CMVG and 10:1 Lipofectamine 2000; for clone 9D4, 10 g CMVG with 10:1 Lipofectamine 2000. Following 16 h of transfection, the medium was changed to normal growth medium. At day 2 post transfection, medium was changed to 12.5 ml of growth medium supplemented with 10 mM HEPES (collection medium) and conditioned medium collected 24 h later at 3 days post transfection. To maximize the amount of virus obtained from a single transfection, when day 3 conditioned medium was removed, it was replaced with an additional 12.5 ml of collection medium and collected at day 4. To concentrate the virus, medium was Wltered through 0.2 M Wlters and concentrated by centrifugation at 58,000 RCF for 45 min in an SW28 rotor at 4°C. Viral pellets were resuspended in 30 l of calcium and magnesium free PBS supplemented with 10 mM HEPES. ZebraWsh embryos were injected with concentrated virus from 9D4, 10D11 or GT186 clones as previously described (Lin et al. 1994 ) and the number of proviral inserts determined using QPCR as described (Amsterdam et al. 1999) . To determine the number of proviral inserts, the Ct values are calculated as outlined above and compared to the Ct values of a standard curve generated using genomic DNA containing a known number of proviral copies.
PCR analysis of viral insertions
For inverse PCR, genomic DNA was digested with Taq1 (NEB) and diluted twofold for ligation. PCR was performed with primers either for the left side LTR or right side LTR of the provirus using Phusion polymerase (Finnzymes) to ensure ampliWcation of large products. For linker-mediated PCR, genomic DNA was digested with Tsp509I followed by incubation with 10 g/ml Proteinase K to digest the enzyme. Linkers were subsequently ligated onto the fragments and nested PCR was performed using primers for the left side or the right side of the viral insertion. Products were separated on a 2% agarose gel, puriWed from the gel, and directly sequenced. To determine location of the viral insertion, BLAST searches were performed for the resulting sequences to the zebraWsh assembly version 7 and only unambiguous alignments are reported. To genotype for a speciWc insertion, a primer for the genomic location was used in conjunction with a primer for the LTR of the virus.
Expression analysis
For RT-PCR, pools of embryos were collected from appropriate matings. RNA was isolated using Trizol (Invitrogen) and reverse transcription performed using Transcriptor Reverse Transcriptase (Roche Applied Science) with oligo(dT) containing a T7 adaptor. Two rounds of PCR using Phusion polymerase (Finnzymes) were performed with primers for the viral tag and T7 based step-out primers for the 3Ј end. Products were separated on 1.2% agarose, puriWed and directly sequenced. The sequences were compared using BLAST against the zebraWsh assembly database (Zv7).
For in Situ hybridization, the possible products from the RT-PCR analysis were used as templates for anti-sense probes, as they contain a T7 promoter. For Gal4-VP16, cDNA was cloned into pBluescript II (Stratagene). Antisense probes were generated using the appropriate RNA polymerase (T7 or T3, Promega). Hybridization was performed as previously described (Chen et al. 2001) .
Guanylate cyclase construct expression in zebraWsh embryos and cGMP assay For gucy2F, the full-length cDNA was ampliWed by PCR using Phusion polymerase to reduce the possibility of errors being introduced. For gucy1a3, the full-length cDNA was subcloned from an available IMAGE clone. The cDNAs were placed behind 14£ UAS and a synthetic element containing an intron. These expression cassettes were then inserted into the pBS-I-Sce meganuclease vector (Grabher et al. 2004) . For injection into one-cell stage embryos, plasmid DNA was prepared at a concentration of 30 ng/ l with I-Sce I meganuclease and 1 nl injected into embryos.
To assess cGMP levels, appropriate samples were homogenized in 0.1 M HCl. All samples were acetylated and cGMP levels assessed using a direct cGMP kit (Assay Designs/Stressgen) according to manufacturer's instructions.
Results
Generation of the gene-activating virus
To facilitate a gain-of-function screen in zebraWsh, we constructed a MMLV based virus that contained a UAS responsive promoter. As shown in Fig. 1 , the parent GT vector Golling et al. 2002) was modiWed to include a polyadenylation signal (pA), a tandem UAS-based promoter, and a downstream synthetic element that includes a splice donor. Also included in the construct are the viral LTRs, viral packaging signals and a LacZ gene to allow isolation of virus producing cells. When the provirus is inserted in the correct orientation the pA, in conjunction with a preceding cryptic splice acceptor in the viral vector, is expected to terminate transcription that may be initiated upstream of the insertion. This provides an additional mechanism leading to a loss-of-function insertion and allows these viral insertions to serve a dual purpose. Where the Gal4-VP16 fusion protein is present, transcription should be initiated from the UAS promoter within the provirus and the splice donor of the synthetic element should be joined to the nearest exon, leaving a portion of the viral construct on the transcript which acts as a tag for identiWcation. No initiator ATG is present within the viral tag, therefore, if the insertion occurs upstream of the Wrst coding exon, a full-length protein should be produced. If the viral insertion occurs within an intron, the preceding exons will not be contained in the resulting RNA and may result in a gene product that is constitutively active or dominant negative.
The viral construct was transfected into 293 gp cells, and individual cells selected based on the level of -galactosidase production using FACS. The viral titer produced from each clone was determined by infecting PAC2 zebraWsh Wbroblast cells and determining the proviral inserts by QPCR as described . As shown in Fig. 1b and c, although the modiWcations increased the overall size of the viral vector, there was no negative impact on viral titer. When compared to a previously used viral clone, GT186 , two clones, 9D4 and 10D11, consistently produced more viral insertions in the zebraWsh cell line shown as a negative Ct value due to the normalization to the endogenous rag1 gene (Fig. 1b) . To analyze the ability of these virus producing clones to mutagenize the zebraWsh genome, puriWed, concentrated retrovirus was injected into zebraWsh embryos. The 9D4 and 10D11 clones produced similar numbers of proviral insertions in zebraWsh embryos as the GT186 clone (Fig. 1c) , with an average of ten proviral insertions per cell. While both clones produced virus of similar titer, the 9D4 clone was used for subsequent experiments since 70% of 9D4 injected embryos, compared to 30% of 10D11 injected embryos, survived after 16 h post injection. Large-scale preparations of the 9D4 virus were generated and injected into Tubingen embryos at the 1,000-cell stage and surviving embryos were raised to maturity resulting in approximately 6,000 adult virus injected F0 Wsh.
Germline integration of the gene-activating virus in the zebraWsh genome
To determine whether the UAS-based promoter in the provirus functions as predicted, we characterized germline insertions in a subset of founders. Twenty-one founders Ct values indicate more proviral inserts per cell compared to the GT186 virus. d Infection of zebraWsh embryos with virus from two clones, 10D11 and 9D4. Number of proviral inserts determined using QPCR were outcrossed and the insertions in the F1 Wsh identiWed using inverse PCR and linker-mediated PCR. Inverse PCR on randomly selected F1 embryos (Fig. 2a) indicated the number of unique viral insertions carried varied from a single insertion (family 5 embryo 1) to multiple insertions (family 1). These results are consistent with the data obtained by QPCR and Southern blot analysis (data not shown). From these 21 founders, a subset of F1 Wsh were raised to maturity and the insertions carried by these F1 adults were analyzed using linker-mediated PCR (Fig. 2b) . A total of 70 insertions were characterized, but represents only a fraction of the total insertions carried by the 21 founder Wsh. Table 1 summarizes the insertions, where a known gene or EST may be a target for Gal4-VP16 mediated overexpression. Several of the viral insertions are likely too distant from the nearest gene to result in Gal4-VP16-dependent overexpression. In agreement with data previously observed for the MMLV retrovirus, when predicted genes are included for the collection, the majority of the insertions occur at the 5Ј end of genes: 25 (36%) of the insertions occur in the 1st intron of a gene, 15 (21%) occur in the proximal region within 1 kb of the 1st intron, 13 (19%) insertions occurred in introns other than the Wrst. The remaining 16 insertions (25%) occur at least 1 kb away from the 1st exon as identiWed in the ENSEMBL database. However, many of the initial exons annotated in the zebraWsh database are the Wrst coding exon and non-coding exons, may exist near the viral insertion. This is the case for family pa008 (Portland, Fig. 2 activating), where an insertion on chromosome 3 occurs 12.3 kb upstream of LOC557147, a gene related to Pax6. However, transcript analysis indicated previously unidentiWed 5Ј untranslated exons with the virus insertion occurs 1 kb upstream from an untranslated exon and this gene can be overexpressed in the presence of Gal4-VP16.
Gal4-VP16 induces expression of genes downstream of the viral insertion
There is an orientation dependence to the gene-activating virus; therefore, while the insertions occur within or just upstream of genes, not all of these will be expressed in the presence of Gal4-VP16. When the genomic location of the viral insertions is examined, the nearest gene that may be regulated by Gal4-VP16 can be predicted. However, in some cases, such as with pa010 or pa014, the closest gene on the same strand is more than 20 kb away and may not be overexpressed in the presence of Gal4-VP16. To examine expression of Gal4 induced transcripts, we used a procedure similar to 3Ј RACE that uses the viral tag on the 5Ј end of the transcript and an adaptor for the 3Ј tail to speciWcally amplify the transcripts initiated from the viral insertion. No transcript is identiWed in a pool of embryos obtained by outcrossing founders to wild-type Wsh (Fig. 2d, lanes 2, 4) . In contrast, multiple transcripts are identiWed in a pool of embryos from founder Wsh crossed to Tg(ath5:Gal4VP16) (Fig. 2c) , supporting that Gal4-VP16 eYciently induces transcription of genes downstream from the proviral insertion. Genes induced by Gal4-VP16 were examined for 15 of the 21 families maintained as F1 adults (Table 2 ). The majority [18/21 (86%)] of the identiWed transcripts lie downstream of the viral insertions identiWed in the F1 Wsh, although 3 (14%) transcripts were from insertions not identiWed by LM-PCR or inverse PCR. As expected, where the viral insertion occurs in the Wrst intron, the corresponding transcript begins at the second exon. In many cases, the Wrst exon of the mutated gene is noncoding, and a full-length protein is expected from these viral-initiated transcripts. Interestingly, some of the identiWed transcripts contain noncoding exons that have not been previously annotated. Two (9.5%) transcripts identiWed contain spliced exonic sequences that do not correspond to an annotated gene in the database; the sequence of these transcripts has been deposited into the EMBL/GenBank data library. These may be novel genes that have not been previously identiWed or may be a result of splicing of cryptic exonic sequences and are artiWcial transcripts initiated from the insertions. Two additional transcripts were identiWed that lie downstream of a viral insertion and contains a single exon, but without an ORF and do not align with an annotated gene. These are most likely artiWcial transcripts and are not included in Table 2 . In one case, pa002, such an artiWcial transcript aligns with a portion of a known gene on the antisense strand and may act as antisense RNAs to decrease the expression of the known gene. We examined the expression pattern of several of these genes in both wild-type and Tg(ath5:Gal4VP16) background. The ath5 promoter has been demonstrated to direct expression to the retinal ganglion cells, as well as ectopic expression in the olfactory bulb . In these transgenic Wsh, onset of Gal4-VP16 expression is at 24 h post fertilization (hpf) (Fig. 3a) with expression in a few cells in the ventral retina as well as slight expression in the olfactory bulb. At 50 hpf, there is a marked increase in expression which encompasses the entire retina (Fig. 3b) , but the expression in the olfactory bulb is much weaker. Genes downstream of viral insertions are expressed in a similar pattern. For example, at 48 hpf, nedd8, a gene downstream of a viral insertion identiWed in pa010, is not normally expressed in the retina in embryos that carry the viral insertion, but not ath5:Gav4VP16 (Fig. 3c) . In embryos that carry both ath5:Gal4VP16 and the viral insertion, the expression of nedd8 is prominent in the retina (Fig. 3d) . At 48 hpf, the expression pattern of the nedd8 is primarily in the ventral retina. This slight restriction in expression domains suggests that the Gal4-VP16 fusion protein may need to accumulate to a suYcient level to induce expression from the viral insertion, which in this Gal4-VP16 transgenic line appears to occur predominantly in the ventral retina at this stage. We also examined expression of another candidate gene in embryos at a later stage. This target gene, a Pax6-like gene identiWed in family pa008, was found to be expressed in neurogenic regions at early stages of development in wild-type embryos (data not shown). At 54 hpf, expression is barely detectable (Fig. 3e) . However in embryos that carry the upstream viral insertion as well as ath5:Gal4VP16, expression in the retina continues to be detected at 54 hpf and is restricted to the retinal ganglion cell layer (Fig. 3f) . Using a separate Gal4-VP16 driver line that is more fully discussed in later sections, we also observe upregulation of an additional target gene in cells, where Gal4-VP16 is expressed (Fig. 4b, c) . These data support the Gal4-VP16 dependent activation of genes downstream of viral insertions.
Misexpression of a Gal4-VP16 induced gene results in morphological defects
To determine whether virus-mediated overexpression can lead to a phenotype, we performed two pilot screens using Gal4-VP16 expression lines. The Wrst screen used Tg(ath5:Gal4VP16) as a driver to overexpress tagged genes in progenitors of retinal ganglion cells and individuals were screened at 7-day post fertilization (dpf) for impaired vision using the vision mediated background adaptation (VBA) response (Goldsmith and Harris 2003) . This assay screens for a change in pigmentation when larvae are exposed to a bright light, a known vision mediated process. Because the germline of founders is mosaic, an individual insertion occurs in between 1 and 40% of a clutch with an average of 15% (unpublished observation). To take into account of this mosaicism, 100 larvae from each clutch were screened and only clutches with >5%, but <40% phenotypic embryos were regarded as carrying a putative phenotype-inducing mutation. A total of 1,500 founder Wsh were screened in this manner. However, linkage analysis of the 21 families with a putative phenotype using both Southern blot and linker-mediated PCR did not identify any insertion with linkage to the phenotype. We concluded that the screen using Tg(ath5:Gal4VP16) as a driver line was not productive because of several factors. In our hands, the VBA assay was not suYcient to detect what may be a subtle phenotype, since this assay identiWes Wsh with gross defects in retinal 2) and mCherry ¡ embryos (lane 3 and 4) was analyzed. Analysis of the 3Ј end reveals a 3 kb band is present only mCherry + embryos. Analysis of the 5Ј end indicates two splice variants in mCherry + embryos that are not present in the mCherry ¡ embryos. Scale bars are 50 M function. We also determined that the Gal4-VP16 expression in the Tg(ath5:Gal4VP16) is too limited and occurs too late to impact retinal development as a whole. Assays to determine more subtle changes in the retina were beyond the scope of this study.
As an alternative, a second screen used a Gal4-VP16 gene/enhancer trap line. This gene/enhancer line was generated using Tol2 transgenesis to deliver a cassette consisting of a UAS driven mCherry and the hsp70 basal promoter to drive Gal4-VP16 in conjunction with transcriptional elements near the insertion. This gene/enhancer trap line carries an insertion in the 14-3-3 epsilon gene and displays strong mCherry throughout the CNS (Fig. 4a) beginning at 12 somites. We crossed these Gal4-VP16 expressing Wsh to the F1s carrying viral insertions from the 21 families that were maintained from the pilot retinal screen. After screening ten of the 21 F1 families, one interesting phenotype was identiWed. In one family, when compared to a normal sibling (Fig. 4e) , the F2 larvae at 5 dpf displayed a shortened body, hemorrhage in the brain (Figs. 4d, 5a, b, d ) and a loss of neurons in the forebrain (Fig. 4f) . This family, pa0028, carries multiple insertions, however only one insertion showed linkage with the phenotype (Fig. 4g ). This insertion is upstream of gucy2F, a Type 1 membrane-bound guanylate cyclase normally expressed exclusively in the retina (Yang et al. 1995; Yang and Garbers 1997; Baehr et al. 2007 ). Additional analysis of mutant embryos from multiple crosses supports linkage of this insertion and the phenotype (Fig. 4h) .
We examined the transcript generated from this virus insertion. We used a primer speciWc to the viral tag and a primer speciWc to gucy2F to ensure expression was a result of Gal4 induction. We also examined the 3Ј end of the transcript, which gives an indication of gucy2F expression, but is not exclusive to a Gal4 induced transcript. In 24 hpf embryos that contain both the viral insertion and Gal4-VP16, we readily detected the UAS directed transcript of gucy2F (Fig. 4i, lanes 1, 2) . No transcript was identiWed using RNA from 24 hpf embryos that carried the viral insertion, but no Gal4-VP16 (Fig. 4i, lanes 3, 4) suggesting low levels of expression at this stage. This analysis also indicated two alternative splice sites within the Wrst exon and both products should be able to produce a protein Fig. 5 Morphological defects in larvae with overexpression of guanylate cyclases. a-c F2 progeny from a cross of pa0028 virus insertion Wsh to the 14-3-3epsi-lon Gal4-VP16 gene/enhancer trap line. The upper larva has Gal4-VP16 expression, but does not carry the gucy2F viral insertion and is phenotypically normal. The lower larva has both Gal4-VP16 and the gucy2F virus insertion. Dorsal (a) view highlights the forebrain defect (arrowhead) and the shortened trunk, lateral view (b) highlights the hemorrhaging in the brain (arrow). Higher magniWcation of normal larvae (c) and mutant larvae with hemorrhaging in the brain (d, arrow) . e, f Transient expression of gucy2F. Normal, Gal4-VP16 negative (top) and abnormal, Gal4-VP16 positive (bottom) larvae showing shortened trunk and hemorrhaging in the brain although the shorter transcript will lack 200 amino acids at the N-terminus of the protein.
We examined the pattern of expression for gucy2F in normal embryos and in those with expression from the upstream viral insertion. At 24 hpf, there is no expression of gucy2F in embryos without Gal4-VP16 (Fig. 4b ) consistent with the data obtained from the RT-PCR analysis. This is not surprising since gucy2F has been described as restricted to photoreceptors (Yang et al. 1995) , which have yet to develop at this stage. In contrast, in embryos that carry the viral insertion and Gal4-VP16 expression from the gene-trap cassette, strong expression of gucy2F is detected in the same pattern as mCherry (Fig. 4c) . Since these embryos go on to develop abnormally, this provides a good correlation between overexpression of a gene downstream of a viral insertion and a phenotype and supports the gain-of-function approach in zebraWsh.
To further tie overexpression of gucy2F and the development of this phenotype, embryos carrying the gene-trap cassette resulting in Gal4-VP16 expression in neurons were injected with a UAS driven gucy2F cDNA. At 4 dpf, we observed a phenotype similar to that of gucy2F expression from the viral insertion. SpeciWcally, injected larvae with Gal4-VP16 expression have a shortened body and visible hemorrhaging in the brain (Fig. 5e , f-lower larvae). These phenotypes were not observed in larvae that were injected with UAS driven gucy2F cDNA, but lack Gal4-VP16 expression (Fig. 5e, f-upper panels) . This supports that the phenotype observed in the family of pa0028a F2 Wsh is a result of gucy2F overexpression and not a gene downstream from another viral insertion.
One potential mechanism leading to this abnormal phenotype is an overall increase in the levels of cGMP. To investigate if cGMP regulation may be altered in these larvae, we assayed cGMP levels in the mutant larvae arising from gene-activation from the upstream viral insertion as well as examining cGMP levels in the larvae injected with the expression constructs. At 5 dpf, the pa0028 mutant larvae had a ninefold increase levels in cGMP when compared to normal siblings (Fig. 6) . Similarly, the larvae injected with the gucy2F construct showed a tenfold increase in cGMP at 24 hpf, a time where there should be an expression of gucy2F from the injected plasmid. The increase in cGMP levels suggests that aberrant production of cGMP due to gucy2F expression plays a central role in the development of the mutant phenotype.
These studies indicate that this gain-of-function approach is a viable method in a vertebrate model in order to identify new genes involved in developmental processes. Using MMLV as a tool to deliver a Gal4 responsive cassette into the genome, thousands of genes can easily be targeted. In conjunction with a Gal4-VP16 expression in tissues of interest, genes can be overexpressed and the resultant phenotypes observed. This approach may uncover genes that have been previously overlooked in loss-of-function screens.
Discussion
In Drosophila, gain-of-function screens using gene-activation have been useful to identify genes involved in a number of developmental processes (Hay et al. 1997; Staudt et al. 2005; Molnar et al. 2006 ). Here we sought to use an analogous approach in a vertebrate system to demonstrate the utility of gain-of-function in zebraWsh and the MMLV retrovirus as an agent for cassette delivery into the genome. As has been highlighted by others (Wu et al. 2003; Wang et al. 2007 ) and further supported by this work, the MMLV mediated viral integrations that occur within genes are primarily at the 5Ј end of the gene. For the UAS containing virus, this allows the simultaneous production of a loss-offunction insertion and the ability to overexpress the downstream gene when Gal4-VP16 is present. In a screen of F1 Wsh, the loss-of-function insertion should have minimal impact since only one allele is altered. However, in subsequent generations, the loss-of-function phenotype can be examined for genes of interest. When insertions occur in 5Ј non-coding regions, the protein resulting from Gal4-VP16 activation should function normally. If the viral insertion occurs within an intron in the coding regions, this could yield a truncated protein with dominant negative or aberrant function. During the analysis of transcripts induced by Gal4-VP16, we discovered there may be cryptic splice acceptor sites throughout the zebraWsh genome. Many of these artiWcial transcripts likely have no function, although the possibility exists that some of them represent previously Fig. 6 Increased cGMP in embryos with gucy2F overexpression. cGMP levels assayed at 5 dpf for pa0028 mutant larvae and normal siblings and 24 hpf embryos injected with the gucy2F expression construct. Increased cGMP levels are detected in those embryos that have overexpression of gucy2F. No diVerence in cGMP levels due to the presence of unidentiWed genes. It is also important to consider that due to the expression of Gal4-VP16, the gene downstream of the viral insertion may now be present in cells or tissues, where it would not normally be expressed. This is the case for gucy2F expression in the CNS. Although it is simple to discount this as merely an artifact, a phenotype induced by misexpression may reveal important information regarding the function of a related gene or biological process.
In this study, only a small number of insertions were examined in detail compared to the number generated. However, this study provides important information about the gain-of-function approach. The virus readily integrates into the zebraWsh genome and at least one insertion is transmitted to each progeny. This suggests that a large number of insertions can be analyzed. On average, each founder carries insertions that can produce at least two unique Gal4-inducible transcripts (Fig 2c) . Therefore, the 6,000 founders we generated may contain at least 12,000 activating mutations, likely covering a signiWcant portion of the zebraWsh genome.
During the course of this study, we discovered in order to impact a developmental process, it is necessary to have a robust assay and to have Gal4-VP16 induced expression at the appropriate time, place and at an adequate level. This is highlighted by our initial phenotype based screen using Tg(ath5:Gal4VP16) Wsh as the driver line. This screen was designed to identify gross changes in retinal development using the VBA assay and was unable to identify more subtle phenotypic changes. The Gal4-VP16 expression in the transgenic line begins just as cells in the retina begin to diVerentiate and is likely unable to impact the overall function of the retina. However, using the 14-3-3 epsilon gene/ enhancer trap line revealed that phenotype based screens using this gain-of-function approach is a viable approach. Although we used a small sample size, we found a phenotype in one of ten founders screened, which are estimated to carry about 20 activating mutations. This phenotype is easily identiWable and linked with a speciWc virus insertion. While the range of gain-of-function screens in Drosophila (Staudt et al. 2005; Molnar et al. 2006) , the true frequency would need to be determined with a larger collection of founders carrying viral insertions.
Overexpression of gucy2F in the CNS clearly leads to an abnormal phenotype. The signiWcance of this observation can be debated since gucy2F is normally restricted to the retina, however it does yield useful information about cGMP in neurons. The increase in cGMP levels likely plays a central role in this phenotype, which suggests that precise control of cGMP in neurons is necessary. This process would be controlled by a guanylate cyclase other than GUCY2F. The transient expression of gucy1a3, a guanylate cyclase unrelated to gucy2F, only slightly increased cGMP levels and did not fully recapitulate the phenotype from gucy2F overexpression was (data not shown). The unremarkable increase of cGMP by gucy1a3 overexpression may be related to diVerences in cyclase activation, since GUCY1A3 is dependent on nitric oxide for stabilization and activation (Zabel et al. 1998) . Interestingly, at early stages embryos with gucy2F overexpression appear morphologically normal and proliferation and apoptosis appear to be unchanged (data not shown) suggesting that patterning and early development is not impacted by gucy2F overexpression. The abnormal phenotype begins at 4 dpf and severe defects evident by 7 dpf. This suggests that the phenotype may be due to neuronal degeneration rather than a developmental defect.
The observed brain hemorrhaging may be related to neurodegeneration phenotype. It may be a consequence of high concentration of extracellular cGMP released from dying neurons. High levels of cGMP can induce apoptosis of endothelial cells (Suenobu et al. 1999) . However, it is not known how much extracellular cGMP in the brain can enter endothelial cells. Alternatively, the hemorrhaging may induce neurodegeneration. The hemorrhaging suggests defects in the blood-brain barrier, which has been suggested to be an element in neuronal degeneration with such diseases as Parkinson's disease (Desai et al. 2007; Monahan et al. 2008) . Nevertheless, the two phenotypes may be independent.
In this study, we demonstrate that the gene-activation approach can be applied in a forward genetic screen in zebraWsh by using MMLV as a method to deliver a UAS driven cassette into the genome. This is a versatile approach since once Wsh with viral insertions are generated; they can be used in a variety of screens assaying eVects in diVerent tissues or cell types. However for this to be a robust approach, it requires appropriate Gal4-VP16 expression in tissues or cell types of interest, and appropriate assays to identify mutant phenotypes. By applying this gain-of-function approach, we identiWed that appropriate control of cGMP production is needed for neuronal survival. The availability of this gain-of-function approach in a vertebrate system should facilitate the identiWcation of new genes or previously unknown roles of known genes in development and diseases.
